FACTORS PREDICTING COURSE OF BETA-CELL FUNCTION IN IDDM

被引:41
作者
SCHIFFRIN, A
SUISSA, S
WEITZNER, G
POUSSIER, P
LALLA, D
机构
[1] ROYAL VICTORIA HOSP,MCGILL NUTR & FOOD SCI CTR,MONTREAL H3A 1A1,QUEBEC,CANADA
[2] MONTREAL GEN HOSP,DIV EPIDEMIOL & BIOSTAT,MONTREAL H3G 1A4,QUEBEC,CANADA
关键词
D O I
10.2337/diacare.15.8.997
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The purpose of this study was to determine whether the severity of clinical presentation, sex, age, HLA type, and the presence of IAs and ICAs could predict the variation of residual insulin secretion as measured by the serum C-peptide response to a Sustacal meal. RESEARCH DESIGN AND METHODS - A cohort of 151 newly diagnosed IDDM children (mean age 10.2 +/- 4.6 yr) was followed prospectively for 3 yr. Thirty-five patients (12 males, 23 females) were still secreting C-peptide after 36 mo. RESULTS - We found that age (P = 0.0001), sex (P = 0.003), presence of ICA (P = 0.006), severity of clinical presentation (P = 0.001), and symptom duration (P = 0.002) significantly predicted the rate of loss of C-peptide secretion. The risks of accelerated C-peptide disappearance decreased with increasing age, the risk ratios being 0.25 for the older group (> 12 yr) compared with the younger group (< 6 yr) and 0.50 for the intermediate group (6-12 yr) compared with the younger group. The risk for the presence of ICA was 1.7, and the risk for males was 1.7 also. There was a significant negative correlation between ICA titers and C-peptide at 18 and 24 mo after diagnosis (P = 0.04). There were no significant differences in HbA1 values between patients who secreted C-peptide and those who did not. CONCLUSIONS - We conclude that younger age of onset, male sex, high titers of ICA, severe clinical presentation, and shorter symptom duration significantly predict accelerated rates of loss of C-peptide secretion.
引用
收藏
页码:997 / 1001
页数:5
相关论文
共 24 条
[1]   IMPAIRED INSULIN ACTION IN PUBERTY - A CONTRIBUTING FACTOR TO POOR GLYCEMIC CONTROL IN ADOLESCENTS WITH DIABETES [J].
AMIEL, SA ;
SHERWIN, RS ;
SIMONSON, DC ;
LAURITANO, AA ;
TAMBORLANE, WV .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (04) :215-219
[2]  
[Anonymous], 1971, STAT PRINCIPLES EXPT
[3]   FACTORS ASSOCIATED WITH EARLY REMISSION OF TYPE-I DIABETES IN CHILDREN TREATED WITH CYCLOSPORINE [J].
BOUGNERES, PF ;
CAREL, JC ;
CASTANO, L ;
BOITARD, C ;
GARDIN, JP ;
LANDAIS, P ;
HORS, J ;
MIHATSCH, MJ ;
PAILLARD, M ;
CHAUSSAIN, JL ;
BACH, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (11) :663-670
[4]  
CIAMPI A, 1990, J CLIN EPIDEMIOL, V43, P701
[5]   RESIDUAL BETA-CELL FUNCTION AND ISLET CELL ANTIBODIES IN DIABETIC CHILDREN [J].
CROSSLEY, JR ;
JAMES, AG ;
ELLIOTT, RB ;
BERRYMAN, CC ;
EDGAR, BW .
PEDIATRIC RESEARCH, 1981, 15 (01) :62-65
[6]  
DANILOUS J, 1990, HISTOCOMPATIBILITY T, P287
[7]  
ELLIOTT RB, 1981, LANCET, V2, P1
[8]   RADIOIMMUNOLOGICAL DETERMINATION OF HUMAN C-PEPTIDE IN SERUM [J].
HEDING, LG .
DIABETOLOGIA, 1975, 11 (06) :541-548
[9]  
KALBFLEISCH J, 1981, STATISTICAL ANAL FAI
[10]   INSULIN AUTOANTIBODIES AT THE CLINICAL MANIFESTATION OF TYPE-1 (INSULIN-DEPENDENT) DIABETES - A POOR PREDICTOR OF CLINICAL COURSE AND ANTIBODY-RESPONSE TO EXOGENOUS INSULIN [J].
KARJALAINEN, J ;
KNIP, M ;
MUSTONEN, A ;
AKERBLOM, HK .
DIABETOLOGIA, 1988, 31 (03) :129-133